RAMM Pharma Corp. RAMM
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.25% | 37.13% | 44.03% | 47.12% | -47.68% |
| Total Depreciation and Amortization | -47.20% | -52.55% | -46.73% | -41.08% | -24.46% |
| Total Amortization of Deferred Charges | 142.86% | 85.71% | 28.57% | -42.86% | -- |
| Total Other Non-Cash Items | -59.37% | -45.11% | -55.21% | -55.32% | 169.57% |
| Change in Net Operating Assets | 61.43% | 3.39% | 37.50% | 76.84% | 2,811.64% |
| Cash from Operations | 19.26% | 35.41% | 63.70% | 74.39% | 67.24% |
| Capital Expenditure | -- | -- | 141.12% | 100.00% | 72.13% |
| Sale of Property, Plant, and Equipment | 16.59% | 38.23% | -- | -- | 475.83% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -118.45% |
| Cash from Investing | 20.87% | 47.71% | 1,615.80% | 2,608.43% | 685.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 67.41% | 72.66% | 61.78% | 43.63% | 19.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -116.46% | -153.09% | -- | -- | 92.94% |
| Cash from Financing | 62.97% | 66.88% | 59.13% | 42.33% | 24.65% |
| Foreign Exchange rate Adjustments | 46.75% | -43.59% | -232.23% | -1,780.00% | -138.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.36% | 68.52% | 114.36% | 99.75% | 79.97% |